WeVote

Bill

Bill

HB 910

RELATING TO RARE DISEASES.

2026 Regular Session Introduced by Cory Chun and 7 co-sponsors

HB 910 establishes or expands Hawaii's rare disease support measures, likely addressing diagnosis access, treatment equity, or patient services through health policy changes.

Carried over to 2026 Regular Session.
0
WeVote Research Nonpartisan
Bill Summary · HB 910

Legislative bill overview

HB 910 addresses rare diseases in Hawaii, though the full text is not provided in your summary. Based on the committee referrals (Health, Education, Consumer Protection, and Finance), the bill likely proposes measures related to rare disease diagnosis, treatment access, patient support, or healthcare provider education. The bill was introduced in January 2025 and carried over to the 2026 session, indicating it did not advance to passage in the initial legislative period.

Why is this important

Rare diseases affect a small percentage of the population but collectively impact thousands of Hawaii residents who face significant challenges accessing diagnosis, treatment, and support services. These conditions are often under-researched and under-resourced, making state-level policy intervention necessary to improve patient outcomes and healthcare system preparedness.

Potential points of contention

  • Healthcare cost burden: Rare disease treatments are frequently expensive; the bill may propose state funding, insurance mandate requirements, or subsidies that could affect state budgets or premium costs
  • Scope and definition clarity: Disagreement may arise over which diseases qualify as "rare" and what specific support services the state should provide versus leaving to federal programs
  • Provider expertise requirements: If the bill mandates provider training or specialty clinic development, rural areas and smaller healthcare systems may face implementation challenges

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.